Diseases Associated With Negative Regulation Of Protein Oligomerization
Disease |
Hyperglycemia
|
Diabetes Mellitus
|
Diabetes Mellitus, Type 1
|
Alzheimer's Disease
|
Cholestasis
|
Diabetes Mellitus, Insulin-Dependent, 2
|
Diabetes Mellitus, Permanent Neonatal
|
Diabetes Mellitus, Type 2
|
Diabetic Cardiomyopathies
|
Diabetic Ketoacidosis
|
Diabetic Nephropathy
|
Drug-Induced Liver Injury
|
Edema
|
Epidermodysplasia Verruciformis
|
Epilepsy
|
Fatty Liver
|
Glucose Intolerance
|
Heart Arrest
|
Heart Failure
|
Hepatitis
|
Hyperinsulinism
|
Hyperkalemia
|
Hypertension
|
Hypertriglyceridemia
|
Hypoglycemia
|
Hypokalemia
|
Hypotension
|
Orthostatic Hypotension
|
Insulin Resistance
|
Intellectual Disability
|
Kidney Diseases, Cystic
|
Lewy Body Dementia
|
Liver Cirrhosis, Experimental
|
Liver Failure, Acute
|
Maturity-Onset Diabetes Of The Young, Type 1
|
Memory Disorders
|
Metabolic Diseases
|
Metabolic Syndrome X
|
Muscular Diseases
|
Neoplasm Invasiveness
|
Neural Tube Defects
|
Neurocognitive Disorders
|
Obesity
|
Pancreatitis
|
Panic Disorder
|
Paralysis
|
Paresthesia
|
Parkinson's Disease
|
Pneumoconiosis
|
Polycystic Ovary Syndrome
|
Prostatic Neoplasms
|
Renal Insufficiency
|
Rhabdomyolysis
|
Seizures
|
Drug Dependence
|
Substance Withdrawal Syndrome
|
Tachycardia
|
Telomeric 22q13 Monosomy Syndrome
|
Urinary Bladder Diseases
|
Ventricular Dysfunction, Left
|
Ventricular Fibrillation
|
Ventricular Outflow Obstruction
|
Acute Kidney Injury
|
Weight Loss
|
Albuminuria
|
Bipolar Disorder
|
Cardiomyopathy, Hypertrophic
|